ZENDERAV Trademark

Trademark Overview

On Friday, March 24, 2017, a trademark application was filed for ZENDERAV with the United States Patent and Trademark Office. The USPTO has given the ZENDERAV trademark a serial number of 87384652. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 5, 2025. This trademark is owned by Bayer Aktiengesellschaft. The ZENDERAV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
zenderav

General Information

Serial Number87384652
Word MarkZENDERAV
Filing DateFriday, March 24, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 5, 2025
Registration Number5683008
Registration DateTuesday, February 26, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 11, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 5, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBayer Aktiengesellschaft
Party Type30 - Original Registrant
Legal Entity Type99 - Other
Address51373 Leverkusen
DE
Party NameBayer Aktiengesellschaft
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address51373 Leverkusen
DE
Party NameBayer Aktiengesellschaft
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address51373 Leverkusen
DE

Trademark Events

Event DateEvent Description
Tuesday, March 28, 2017NEW APPLICATION ENTERED
Wednesday, March 29, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 6, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 10, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, July 10, 2018SUSPENSION INQUIRY WRITTEN
Tuesday, July 10, 2018INQUIRY TO SUSPENSION E-MAILED
Tuesday, July 10, 2018NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, July 23, 2018ASSIGNED TO LIE
Saturday, June 17, 2017ASSIGNED TO EXAMINER
Saturday, June 17, 2017SUSPENSION LETTER WRITTEN
Saturday, June 17, 2017LETTER OF SUSPENSION E-MAILED
Saturday, June 17, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, January 9, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, February 6, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 26, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 26, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 11, 2018PUBLISHED FOR OPPOSITION
Tuesday, September 11, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 6, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 26, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 3, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 22, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 18, 20191(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, February 26, 2019REGISTERED-PRINCIPAL REGISTER
Monday, February 26, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 17, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 17, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 5, 2025CANCELLED SEC. 8 (6-YR)
Tuesday, December 17, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, December 2, 2018TEAS DELETE 1(B) BASIS RECEIVED
Sunday, December 2, 2018NOTICE OF ALLOWANCE CANCELLED
Friday, January 18, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords

zenderav cancer treatment preparations pharmaceutical